Ocular Drug Delivery Market is expected to reach US$ 27,016.20 million by 2028

1
Ocular Drug Delivery Market 
Ocular Drug Delivery Market Forecast to 2028 -
COVID-19 Impact and Global Analysis By Technology
(Implantable Ocular Drug Delivery Systems,
Particulate Drug Delivery Systems, Nano-Particle
Drug Delivery System, and Others), Formulation
Type (Liposomes and Nanoparticles, Solution,
Emulsion, Suspension, and Ointment), Disease Type
(Glaucoma, Diabetic Retinopathy, Dry Eye
Syndrome, Macular Degeneration, Cataract,
Diabetic Macular Edema, and Others), and End User
(Hospitals, Ophthalmic Clinics, and Ambulatory
Surgical Centers) and Geography
2
Current and future Market Scenario
Ocular Drug Delivery Market 
According to our new market research study on
Ocular Drug Delivery Market to 2028 Global
Analysis and Forecast by Technology,
Formulation Type, Disease Type, and End User,
the market is expected to reach US 27,016.20
million by 2028 from US 16,404.32 million in
2021 it is expected to grow at a CAGR of 7.4
from 2021 to 2028. The report highlights trends
prevailing in the market and drivers and
hindrances pertaining to the market growth.
3
Market Segments
Ocular Drug Delivery Market
By Disease Type Glaucoma, Diabetic
Retinopathy, Dry Eye Syndrome, Macular
Degeneration, Cataract, Diabetic Macular
Edema, Others
By Formulation Type Liposomes and
Nanoparticles, Solution, Emulsion, Suspension, Oin
tment
By Technology Implantable Ocular Drug Delivery
Systems Particulate Drug Delivery
Systems, Nano-Particle Drug Delivery
System, Others
4
Leading Players
Ocular Drug Delivery Market  
Company Profiles in Ocular Drug Delivery Market
are AbbVie Inc.
Bausch Health Companies Inc.
Taiwan Liposome Company, Ltd.
Ocular Therapeutix, Inc.
GRAYBUG VISION, INC.
Alimera Sciences, Inc.
Envisia Therapeutics
Novartis AG
EYEGATE PHARMACEUTICALS, INC
Clearside Biomedical, Inc.
5
Ocular Drug Delivery Market  
Access Full Research Report at
https//www.theinsightpartners.com/reports/ocular-
drug-delivery-market
Thank You!

• Thank You!